We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-5.45%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$937M
AUM Growth
+$469M
Cap. Flow
+$599M
Cap. Flow %
63.92%
Top 10 Hldgs %
34.62%
Holding
195
New
53
Increased
82
Reduced
19
Closed
41

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.4%
2 Technology 15.87%
3 Consumer Staples 7.14%
4 Communication Services 7.12%
5 Healthcare 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DIN icon
76
Dine Brands
DIN
$453M
$3.44M 0.37%
55,731
-376
-0.7% -$28K
SNEX icon
77
StoneX
SNEX
$7.81B
$3.32M 0.35%
272,135
+65,529
+32% +$911K
GDXJ icon
78
VanEck Junior Gold Miners ETF
GDXJ
$8.54B
$3.24M 0.35%
69,128
-1,067
-2% -$45.9K
CNVY
79
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
$3.21M 0.34%
594,347
+337,396
+131% +$2.23M
SNAP icon
80
Snap
SNAP
$9.05B
$3.1M 0.33%
+105,198
New +$3.8M
HBB icon
81
Hamilton Beach Brands
HBB
$444M
$3.05M 0.33%
311,541
+159,564
+105% +$2.07M
FLWS icon
82
1-800-Flowers.com
FLWS
$255M
$3.02M 0.32%
+236,610
New +$4.07M
COUR icon
83
Coursera
COUR
$1.52B
$2.94M 0.31%
+127,826
New +$2.62M
TZOO icon
84
Travelzoo
TZOO
$73.9M
$2.86M 0.31%
499,000
-5,869
-1% -$49.8K
GER
85
DELISTED
Goldman Sachs MLP Energy Renaissance Fund
GER
$2.8M 0.3%
229,135
+94,592
+70% +$1.09M
MAPS
86
DELISTED
WM TECHNOLOGY INC A
MAPS
$2.74M 0.29%
435,709
+162,068
+59% +$920K
FL
87
DELISTED
Foot Locker
FL
$2.53M 0.27%
104,331
+83,405
+399% +$3.19M
CAL icon
88
Caleres
CAL
$486M
$2.5M 0.27%
162,993
+109,609
+205% +$2.38M
SENEA icon
89
Seneca Foods Class A
SENEA
$1.22B
$2.47M 0.26%
58,883
-3,563
-6% -$175K
NTUS
90
DELISTED
Natus Medical Inc
NTUS
$2.47M 0.26%
121,061
+50,028
+70% +$1.22M
AXTA icon
91
Axalta
AXTA
$8.01B
$2.44M 0.26%
+120,449
New +$3.37M
FBP icon
92
First Bancorp
FBP
$4.42B
$2.42M 0.26%
231,925
-204,314
-47% -$2.91M
MED icon
93
Medifast
MED
$135M
$2.23M 0.24%
+15,836
New +$2.99M
VSXY
94
Victoria's Secret
VSXY
$7.95B
$2.16M 0.23%
+51,860
New +$2.82M
RLGT icon
95
Radiant Logistics
RLGT
$390M
$2.12M 0.23%
406,873
+188,308
+86% +$1.25M
MLR icon
96
Miller Industries
MLR
$606M
$2.08M 0.22%
92,429
+68,040
+279% +$2.1M
UHS icon
97
Universal Health Services
UHS
$10.5B
$2.07M 0.22%
17,648
-676
-4% -$93.5K
UA icon
98
Under Armour Class C
UA
$2.42B
$2.06M 0.22%
+163,559
New +$2.56M
CVEO icon
99
Civeo
CVEO
$330M
$1.94M 0.21%
100,412
+4,691
+5% +$104K
LYB icon
100
LyondellBasell Industries
LYB
$20.2B
$1.91M 0.2%
18,611
-2,166
-10% -$216K

Similar funds

Invenomic Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Invenomic Capital Management held 195 positions worth $937M, up 100% from $468M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Invenomic Capital Management deployed $599M of net new capital in Q1 2022, opening 53 new positions and adding to 82 existing holdings. Its largest new stake was Rover Group, Inc. Class A Common Stock: 2,877,600 shares worth $16.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 12% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Stride, an estimated $3.67M trimmed.

  • Invenomic Capital Management's largest Q1 2022 buy was Rover Group, Inc. Class A Common Stock: 2,877,600 shares worth $16.6M.
  • Invenomic Capital Management added most to Dropbox in Q1 2022, an estimated $19.2M increase.
  • Invenomic Capital Management's biggest Q1 2022 reduction was Stride, cutting an estimated $3.67M.
  • Invenomic Capital Management fully exited Triple-S Management Corporation in Q1 2022, selling an estimated $8.68M.
  • Invenomic Capital Management's ten largest holdings make up 35% of its $937M portfolio in Q1 2022.
  • Invenomic Capital Management opened 53 new positions and closed 41 in Q1 2022.
  • Invenomic Capital Management's portfolio value rose 100% quarter-over-quarter to $937M.

Based on Invenomic Capital Management's 13F filing for Q1 2022, filed 16 May 2022.